Trial Profile

A Randomized, Double-Blind, Single-Dose, 5-Period Crossover Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Subjects With Narcolepsy Type 1

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 01 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

16 Feb 2026 According to the Eisai Co Ltd Media Release, the company presented data from a Phase Ib clinical study in patients with narcolepsy type 1 at the World Sleep 2025 congress.
08 Sep 2025 According to the Eisai Co Ltd Media Release, There were a total of 21 patients in the clinical trial (21 patients received the study medication, 19 patients completed the trial).
08 Sep 2025 Results published in the Media Release

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com